New Approaches to Diagnostics and Therapy for COVID-19

Although several clinical trials are now underway to test possible therapies, the issue of reliable therapy for COVID-19 remains debatable. We report here the new approach to individual selection of Dexamethasone and Ribavirin doses used in COVID-19 therapy. For the first time “the device for transmission of Ribavirin pharmacological properties to a human body” was used to eliminate the virus from the COVID-19 patients' body quickly and safely. Dexamethasone and Ribavirin are included in the WHO List of Essential Medicines. The proposed methods of “medicament testing” as well as the application of “the device for transmission of Ribavirin pharmacological properties to a human body” need further investigation for possible benefits for coronavirus infection therapy.